Mistaken information. please delete
-
Last edited by Aniki; 11-19-2013, 08:19 AM. -
Hi Aniki,
We are committed to providing our 454 instruments, parts, reagents, consumables, service and support for all our 454 products currently on the market over the next three years until mid-2016. We will also be offering new updates, including longer reads for the GS Junior System (both random fragment and amplicon libraries),
If you have any specific questions or concerns I encourage you to reach out to your local Roche service representative.
Best Regards,
Nicole
Senior Support Specialist
454 Life Sciences, A Roche Company -
Dear Nicole,
my apologies, I was given information that Roche will no longer support the 454. Please accept my sincerest apology for the confusion.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment